Hamed EM,Meabed MH,Aly UF,Hussein RRS .2019 .Recent progress in gene therapy and other targeted therapeutic approaches for beta thalassaemia. Curr Drug Targets, 10(16) : 1603-23.
De Sanctis V,Kattamis C,Canatan D,Soliman AT,Elsedfy H,Karimi M .2017 .-Thalassaemia distribution in the old world: An ancient disease seen from a historical standpoint. Mediterr J Hematol Infect Dis, 018(1) : .
Ehsan H,Wahab A,Anwer F,Iftikhar R,Yousaf MN .2020 .Prevalence of transfusion transmissible infections in beta-thalassaemia major patients in pakistan: A systematic review. Cureus, 10(8) : .
Vitrano A,Calvaruso G,Lai E,Colletta G,Quota A,Gerardi C .2017 .The era of comparable life expectancy between thalassaemia major and intermedia: Is it time to revisit the major-intermedia dichotomy?. Br J Haematol, 10(1) : 124-30.
Mulas O,F O,Piroddi MG,Piras A,Vacca E,A E .2023 .Health-related quality-of-life pro le of pediatric patients with ²-thalassaemia after hematopoietic stem cell transplantation. J Clin Med, 10(18) : 6047.
Gaziev J,Isgro A,Sodani P,Marziali M,Paciaroni K,Gallucci C .2016 .Optimal outcomes in young class 3 patients with thalassaemia undergoing HLA-identical sibling bone marrow transplantation. Transplantation, 10(4) : 925-32.
Mathews V,George B,Deotare U,Lakshmi KM,Viswabandya A,Daniel D .2007 .A new strati cation strategy that identi es a subset of class III patients with an adverse prognosis among children with beta-thalassaemia major undergoing a matched related allogeneic stem cell transplantation. Biol Blood Marrow Transplant, 05(8) : 889-94.
Huang C,Qu Y,Liu S,Nie S,Jiang H .2021 .Hematopoietic stem cell transplantation for thalassaemia major using HLA fully matched and mismatched donor grafts. Transl Pediatr, 10(6) : 1552-65.
Hutt D.,Engraftment D.,Kenyon M,Babic A .2018 .The European blood and marrow transplantation textbook for nurses: Under the auspices of EBMT. Cham (CH. , 10 : 13-3.
Iftikhar R,Chaudhry QUN,Satti TM,Mahmood SK,Ghafoor T,Shamshad GU .2020 .Comparison of conventional cyclophosphamide versus udarabine-based conditioning in high-risk aplastic anemia patients undergoing matched-related donor transplantation. Clin Hematol Int, 200426(2) : 82-91.
Chaudhry HM,Bruce AJ,Wolf RC,Litzow MR,Hogan WJ,Patnaik MS .2015 .The incidence and severity of oral mucositis among allogeneic hematopoietic stem cell transplantation patients: A systematic review. Biol Blood Marrow Transplant, 09(4) : 605-16.
Dignan FL,Clark A,Amrolia P,Cornish J,Jackson G,Mahendra P .2012 .Diagnosis and management of acute graft-versus-host disease. Br J Haematol, 09129(1) : 2141-45.
Mohty M,Malard F,Alaskar AS,Aljurf M,Arat M,Bader P .2023 .Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: A re ned classi cation from the European society for blood and marrow transplantation (EBMT). Bone Marrow Transplant, 10(7) : 749-54.
Lucarelli G,Andreani M,Angelucci E. .2002 .The cure of thalassaemia by bone marrow transplantation. Blood Rev, 0192(2) : 81-5.
Bernardo ME,Piras E,Vacca A,Giorgiani G,Zecca M,Bertaina A .2012 .Allogeneic Hematopoietic stem cell transplantation in thalassaemia major: Results of a reduced-- toxicity conditioning regimen based on the use of treosulfan. -04- 423822., 10(2) : 473-6.
Choudhary D,Sharma SK,Gupta N,Kharya G,Pavecha P,Handoo A .2012 .Treosulfan-thiotepa- udarabine-based conditioning regimen for allogeneic transplantation in patients with thalassaemia major: A single-center experience from north India. Biol Blood Marrow Transplant, 11(3) : 492-5.
Mathews V,George B,Viswabandya A,Abraham A,Ahmed R,Ganapule A .2013 .Improved clinical outcomes of high risk ² thalassaemia major patients undergoing a HLA matched related allogeneic stem cell transplant with a treosulfan based conditioning regimen and peripheral blood stem cell grafts. PLoS One, 0061637(4) : .
Faulkner L,Uderzo C,Khalid S,Marwah P,Soni R,Yaqub N .2017 .ATG vs. thiotepa with busulfan and cyclophosphamide in matched-related bone marrow transplantation for thalassaemia. Blood Adv, 10(13) : 792-801.
Yesilipek MA,Uygun V,Kupesiz A,Karasu G,Ozturk G,Ertem M .2022 .Thalassaemia-free and graftv-ersus-host-free survival: Outcomes of Hematopoietic stem cell transplantation for thalassaemia major. Turkish experienceB.one Marrow Transplant, 10(5) : 760-7.
Sablo M,Chandy M,Wang Z,Logan BR,Ghavamzadeh A,Li CK .2011 .HLA-matched sibling bone marrow transplantation for ²-thalassaemia major. -09-306829., 10(5) : 1745-50.
Lai X,Liu L,Zhang Z,Shi L,Yang G,Wu M .2021 .Hepatic veno-occlusive disease/sinusoidal obstruction syndrome after hematopoietic stem cell transplantation for thalassaemia major: Incidence, management, and outcome. Bone Marrow Transplant, 10(7) : 1635-41.
Lucarelli G,Isgro A,Sodani P,Gaziev J .2012 .2(5):a011825. Cold Spring Harb Perspect Med, 10 : .